{"schema_version":"secwatch.filing_event.v1","accession":"0001156039-25-000096","form_type":"8-K","ticker":"ELV","cik":"0001156039","company_name":"Elevance Health, Inc.","filed_at":"2025-05-28T23:59:59+00:00","discovered_at":"2026-05-14T18:02:47.651753+00:00","generated_at":"2026-05-20T07:33:20.801505+00:00","sec_items":["7.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Elevance reaffirms FY2025 adjusted EPS guidance of $34.15-$34.85","bullets":["FY2025 GAAP EPS guidance $28.30-$29.00, including ~$5.85 net unfavorable items.","Adjusted EPS guidance unchanged at $34.15-$34.85.","Benefit expense ratio guidance reaffirmed at 89.1% ± 50 bps.","Company expects 60% of adjusted EPS to be realized in first half of 2025.","Officers reiterate guidance during investor meetings this week."],"urls":{"canonical":"https://secwatch.observer/filing/0001156039-25-000096","json":"https://secwatch.observer/filing/0001156039-25-000096.json","markdown":"https://secwatch.observer/filing/0001156039-25-000096.md","text":"https://secwatch.observer/filing/0001156039-25-000096.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1156039/000115603925000096/0001156039-25-000096-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1156039/000115603925000096/elv-20250528.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-20T07:33:20.801505+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}